OBM Genetics

(ISSN 2577-5790)

OBM Genetics is an international Open Access journal published quarterly online by LIDSEN Publishing Inc. It accepts papers addressing basic and medical aspects of genetics and epigenetics and also ethical, legal and social issues. Coverage includes clinical, developmental, diagnostic, evolutionary, genomic, mitochondrial, molecular, oncological, population and reproductive aspects. It publishes a variety of article types (Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.). There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.

Publication Speed (median values for papers published in 2023): Submission to First Decision: 5.1 weeks; Submission to Acceptance: 17.0 weeks; Acceptance to Publication: 7 days (1-2 days of FREE language polishing included)

Current Issue: 2024  Archive: 2023 2022 2021 2020 2019 2018 2017

Special Issue

New Advances in Mitochondrial Genome Determination and Analysis

Submission Deadline: October 31, 2025 (Open) Submit Now

Guest Editor

Camilla Ceccatelli Berti, PhD

Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, 43124 Parma, Italy

Website | E-Mail

Research interests: Mitochondria; mitochondria disease; mitochondria metabolism; yeast model; genetic and chemical rescue ; genetic variability

About This Topic

Dear Colleagues

In recent decades, the field of mitochondrial genomics has seen tremendous progress, thanks to which we have gained an increasingly detailed understanding of the structure, function, and evolution of the mitochondrial genome. Mitochondria, often described as the “powerhouses” of the cell, play a crucial role not only in energy production but also in numerous cellular processes, including apoptosis, redox signalling and regulation of metabolism. As a result, the study of the mitochondrial genome has become fundamental to several disciplines, from evolutionary biology to medicine.

In this Special Issue, we invite scientists from various fields of research to provide a comprehensive overview of the latest methodologies for sequencing (PacBio, Nanopore, Illumina) and analysis of the mitochondrial genome, new bioinformatics tools, clinical implications of mitochondrial variations (New findings on mitochondrial mutations associated with human diseases; strategies for diagnosis and therapy of mitochondrial diseases), and emerging evolutionary discoveries.

Keywords

Mitochondrial genome; sequencing technologies; bioinformatics; genetic variability; mitochondrial diseases; evolutionary genomics; genomic conservation; forensic genomics; environmental genomics; mutation analysis; functional genomics; comparative genomics; therapeutic targets

Manuscript Submission Information

Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (genetics@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.

Welcome your submission!

Newsletter

TOP